Robert G. Pietrusko
General Counsel bij VOR BIOPHARMA INC.
Profiel
Robert G.
Pietrusko is currently the Chief Regulatory & Quality Officer at Vor Biopharma, Inc. Prior to this, he was the SVP-Regulatory Affairs & Quality Assurance at Voyager Therapeutics, Inc. from 2014 to 2020.
He was also the Senior Vice President-Worldwide Regulatory Affairs at Millennium Pharmaceuticals, Inc. from 2001 to 2007, Vice President-Regulatory Affairs at Shire ViroPharma, Inc. from 2007 to 2009, and Vice President-Regulatory Affairs at GSK Plc from 1999 to 2000.
Dr. Pietrusko received his undergraduate degree from Rutgers State University of New Jersey and his doctorate degree from Philadelphia College of Pharmacy.
Actieve functies van Robert G. Pietrusko
| Bedrijven | Functie | Begin |
|---|---|---|
| VOR BIOPHARMA INC. | General Counsel | 01-04-2020 |
Eerdere bekende functies van Robert G. Pietrusko
| Bedrijven | Functie | Einde |
|---|---|---|
| VOYAGER THERAPEUTICS, INC. | General Counsel | 01-03-2020 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | General Counsel | 01-05-2007 |
| GSK PLC | General Counsel | 01-01-2000 |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | General Counsel | - |
Opleiding van Robert G. Pietrusko
| Rutgers State University of New Jersey | Undergraduate Degree |
| Philadelphia College of Pharmacy | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| GSK PLC | Health Technology |
| VOYAGER THERAPEUTICS, INC. | Health Technology |
| VOR BIOPHARMA INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Health Technology |
